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Abstract
Polybrominated diphenyl ethers (PBDEs) are a pervasive class of brominated flame retardants that are present in the envi-
ronment at particularly high levels, especially in the United States. Their environmental stability, propensity for bioaccu-
mulation, and known potential for neurotoxicity has evoked interest regarding their effects on the developing nervous
system. Exposure to PBDEs has been strongly associated with neurodevelopmental disorders. However, the details of their
mechanistic roles in such disorders are incompletely understood. Here, we report the effects of one of the most prevalent
congeners, BDE-47, and its hydroxylated metabolites on the maturation and function of embryonic rat cortical neurons.
Prolonged exposure to 6OH-BDE-47 produces the strongest effects amongst the parent BDE-47 congener and its tested
hydroxylated metabolites. These effects include: i) disruption of transcriptional responses to neuronal activity, ii) dysregula-
tion of multiple genes associated with neurodevelopmental disorders, and intriguingly, iii) altered expression of several
subunits of the developmentally-relevant BAF (Brg1-associated factors) chromatin remodeling complex, including the key
subunit BAF170. Taken together, our data indicate that persistent exposure to 6OH-BDE-47 may interfere with neurodeve-
lopmental chromatin remodeling mechanisms and gene transcription programs, which in turn are likely to interfere with
downstream processes such as synapse development and overall functional maturity of neurons. Results from this study
have identified a novel aspect of 6OH-BDE-47 toxicity and open new avenues to explore the effects of a ubiquitous environ-
mental toxin on epigenetic regulation of neuronal maturation and function.
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Introduction
Polybrominated diphenyl ethers (PBDEs) are a widely-used class
of organohalogenated flame retardants that were popularized—
and mandated for use in some cases—in the 1970 s. This has led
to their abundance in consumer products including furniture,
electronics, and clothing and therefore within human house-
holds [1]. Moreover, the environmental stability and strong lipo-
philicity of these compounds enables their bioaccumulation,
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specifically in lipid rich adipose and brain tissue [2, 3]. These
characteristics have raised the issue of potential toxicity of
these compounds, leading to the investigation of their effects
on human health [4]. Despite known dangers, the usage and
manufacturing of specific congeners has only recently become
restricted and/or banned in the United States and Europe, and
their presence in the environment will persist for decades to
come [5]. In addition to parent congeners, toxicity may also
arise from metabolic products of PBDEs. In mammals, cyto-
chrome p450 enzymes metabolize PBDEs to form hydroxylated-
BDEs (OH-PBDEs) [6], some of which may be over an order of
magnitude more toxic than the parent compound (e.g., 6OH-
BDE-47) [7–9]. Buildup of such toxic metabolites and their parent
PBDEs from both natural and anthropogenic sources has led to
significant bioaccumulation in humans over the past few deca-
des [10–12]. Human exposure studies suggest that several OH-
PBDEs are present in serum at concentrations similar to, and
sometimes higher than, those of parent PBDEs [13, 14]. Of con-
cern for early neurodevelopment, PBDE and OH-PBDE levels
have been shown to be especially high in young children com-
pared to adults, likely due to mobilization of the compounds
through breastmilk and high exposure rates from household
products and dust [15, 16]. Concerns of such bioaccumulation
are exacerbated by the ability of PBDEs to cross over the pla-
centa, exposing developing fetuses to these toxins [17, 18].
Ominously, several lines of evidence now point towards a
potential role of PBDEs in contributing to various neurodevelop-
mental disorders (NDDs), whose rates of occurrence have grown
to alarming levels in the US [19].
The association between developmental exposures to PBDEs
and NDDs has been extensively studied using mammalian
models. Animals exposed to various PBDEs during prenatal
and/or postnatal periods exhibit long-lasting behavioral abnor-
malities, including deficiencies in motor activity and cognitive
functions [20–23]. Along similar lines, epidemiological studies
in human populations have reported significant associations
of maternal neonatal PBDE exposure with deficits in motor
behavior, Intelligence Quotient (IQ) ratings (showing intellectual
disability), and attention and cognitive functions in children
[24–29]. Recently, an expert panel identified 70-100% probability
that exposure to PBDEs contributes to IQ loss and intellectual
disability that cost the EU public an estimated e9.59 billion
[30]. Among other relevant findings, significant positive correla-
tion has been established between concentration of PBDEs
in postpartum breast milk and increased externalizing behavio-
ral problems [31] (reminiscent of Attention Deficiency
Hyperactivity Disorder (ADHD)-like behavior in older children),
as well as between PBDE concentration in peripheral or cord
blood and increased risk of attention symptoms and poorer
social competency scores [32].
While there is a large amount of correlative evidence for
these effects on humans, disentangling the complex mecha-
nisms of PBDE toxicity has been a difficult task. Of the 209 PBDE
congeners, a few have been the focus of research due to their
prevalence. 2, 2’, 4, 4’-tetrabromodiphenyl ether (BDE-47) is
among the most prevalent PBDE congeners in the environment,
with a correspondingly high body burden in humans [16].
Appropriately, much research has been focused on identifying
the ways in which BDE-47, and to a lesser extent, its hydroxy-
lated metabolites, affect neural cells. Several potential media-
tors of the toxic effects of BDE-47 have been identified,
including: 1) oxidative stress following the uncoupling of mito-
chondrial function by disruption of oxidative phosphorylation
[33], 2) alteration of DNA methylation patterns which were
associated with behavioral deficits in mice [34], 3) disruption of
endocrine signalling– primarily thought to be enabled by struc-
tural similarity with triiodothyronine and thyroxine, as well as
with ligands of other hormone receptors [33–37], and 4) pertur-
bation of calcium homeostasis which has been demonstrated in
several cell types including human neuronal precursors [8, 38].
Despite much progress, a description of how PBDE exposures
are related to NDDs remains incomplete; it is not clear how and
to what extent known molecular and cellular effects of PBDEs
contribute to these adverse phenotypes.
A largely unexplored point of convergence that may help to
provide an integrative explanation of the relationship between
the various effects of PBDE exposures and adverse behavioral
outcomes is epigenetic regulation, specifically of gene transcrip-
tion during neurodevelopment. Epigenetic mechanisms are a
major driving force of normal neurodevelopment [39], and
many neurodevelopmental complications involve dysregulation
of gene transcription [40, 41]. Although several epigenetic com-
ponents of neurodevelopment are now well known, there
remains much more to be characterized [42], especially in
regards to how they interact with environmental challenges
like PBDE exposure. Considering this, we sought to explore the
ways in which exposure to BDE-47, or its hydroxylated metabo-
lites, influences neuronal maturation and function, as well as
the expression of NDD candidate genes, including many epige-
netic regulators.
Methods
Plasmids and Sub-Cloning
A commercial shRNA construct for BAF170 (CCCAAACTGC
TAGGGAAATTA) was obtained from Sigma. This shRNA
sequence was inserted into pLKO.1-puro (designed by RNAi con-
sortium or TRC; obtained from Addgene) and then packaged
into lentiviruses. Self-inactivating HIV lentivirus particles were
produced by transfecting 293 T cells with the shRNA vector,
envelope (pMD2.G; Addgene), and packaging plasmids (psPAX2;
Addgene) using a previously described protocol [43]. The BAF170
expression construct in a lentiviral backbone was a kind gift
from Dr. Trevor Archer (NIEHS, NIH) [44]. BAF170 expression
from this construct was validated by Western blotting.
Dissociated Neuronal Culture, RNAi and Cell Treatment
Cultures of cortical neurons were prepared from embryonic day
18 Sprague Dawley rats (UC Merced IACUC approval: AUP#13-
0007 and AUP#16-0004). Dissociated cortical neurons were
plated in Neurobasal medium (Invitrogen) supplemented with
25 lM glutamate (Sigma-Aldrich) and 0.5 mM L-glutamine
(Sigma-Aldrich) and either B27 (Invitrogen) or NS21 and main-
tained in a similar medium without glutamate. NS21 was pre-
pared in the laboratory as previously described [45]. Neurons
were routinely used for induction assays between 10–16 days
in vitro. For infection with recombinant lentiviruses, the viral
supernatant was diluted in neuronal media and cells were
infected at a multiplicity of infection ranging from 2 to 5. To
induce gene transcription under basal conditions using synaptic
circuits, we co-treated neurons with 50 lM Bicuculline (Sigma-
Aldrich) and 75 lM 4-Aminopyridine (Acros Organics) [46]. To
induce gene transcription extra-synaptically, we blocked activ-
ity with 1 lM TTX (Calbiochem) and induced the MAP-kinase
pathways with 1 lM phorbol 12-myristate 13-acetate (PMA;
Sigma-Aldrich) [47]. BDE-47 and metabolites used to treat
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cultures were obtained from AccuStandard (BDE-047 N, HBDE-
4003 N, HBDE-4004 N, HBDE-4005 N).
RNA Extraction and Gene Transcription Quantitation
Total RNA was isolated from dissociated neurons using the
GeneJET RNA Purification Kit (Thermo) with an off-column
DNase (Promega) digestion. cDNA was synthesized using MuLV
reverse transcriptase (Promega), random primers (Promega),
oligo dTs (Promega), and RNase inhibitors (Thermo Scientific).
Quantitative real-time PCR (qRT-PCR) was performed to quan-
tify mRNA levels of specific transcripts using iTaq Universal
Sybr Green Supermix (BioRad) and the BIO-RAD CFX Connect
realtime PCR Detection System. Pre-mRNA levels were esti-
mated as previously described [43].
Sample Preparation for Electrophoresis
Neurons were lysed in ice-cold 1X RIPA buffer (25 mM Tris, pH
7.5, 150 mM NaCl, 1% Na- deoxycholate, 0.1% SDS, 0.1% NP-40)
supplemented with 1: 100 protease inhibitor cocktail (Sigma-
Aldrich-Aldrich). Lysed neurons were sheared by sonication
(low setting; three cycles on BioruptorVR ), cell debris pelleted at
15 000 rpm for 5 min at 4 C, and clarified supernatant trans-
ferred to pre-chilled 1.5 mL microcentrifuge tube. Total cell
extracts were denatured at 95 C, for 5 min, using either home-
made 5X Laemmli buffer, 2X-, or 4X-Laemmli sample buffer
(both from BIO-RAD).
Western Blotting and Imaging
Denatured protein samples were resolved on 4-20%- (BIO-RAD
cat. no. 4568095) or 4-15%- (BIO-RAD cat. no. 456-1083) Mini
PROTEANVR gels in Tris/Glycine/SDS (BIO-RAD cat. no. 1610772).
Resolved proteins were transferred onto LF PVDF membrane,
using the BIO-RAD TBT RTA kit and protocol (cat. no. 1704272).
PVDF membranes were incubated at 4 C overnight with appro-
priate primary antibodies in 1X TBS-T with 0.5% BSA at 1: 1000
dilution. Primary antibodies included the following antibodies:
bActin (ThermoFisher Scientific AM4302), BAF170 (CST 12760),
BAF155 (CST 11956), Brg1 (CST 49360), BAF47 (CST 91735). Next
day, membranes were washed three times in 1X-TBST, probed
with appropriate Alexa FluorVR secondary antibodies (Life
Technologies) for 40 min at room temperature, washed three
times with 1X TBS-T, and imaged using BIO-RAD Multiplex
ChemiDocTM Imaging System.
Immunocytochemistry and Microscopy
Antibodies for immunocytochemistry were used at dilutions
between 1: 100–1: 500 and include the following: NeuN
(Millipore ABN78), Doublecortin (CST 4604 S), Nestin (Invitrogen
MA1-91657). Neurons were washed twice with 1X ice-cold PBS
(Fisher Sci). The cells were then incubated with 4% paraformal-
dehyde (Sigma-Aldrich) in 1X PBS for 15 min at room tempera-
ture and then washed twice with 1X PBS, permeabilized at room
temperature for 20 min with 0.5% Triton X-100 (Fisher Sci),
washed twice and blocked for 30 min with 10% goat serum
(Gibco) in 1X PBS. Cells were incubated at 4 C overnight in 3%
goat serum in 1X PBS with primary antibodies. Next day, pri-
mary antibody solution was removed and cells were washed
thrice with 0.05% Tween (Fisher) in 1X PBS (0.05% PBS-T), and
incubated with appropriate Alexa FluorVR secondary antibody
(Lifetech) for 45 min, washed thrice with 0.05% PBS-T, cured
overnight with Prolong Anti-Fade Gold with DAPI and imaged.
Images were captured with a Keyence BZ9000-E microscope at
40X magnification.
Cell Viability Assay
Cell viability was assessed by an MTT assay (Biotium) [48]
wherein mitochondrial activity is detected colorimetrically fol-
lowing incubation of cells with a tetrazolium salt. The assay
was conducted according to manufacturer’s instruction, except
that MTT incubation time was shortened to 30 min to avoid
reaching a plateau where differences in product formation
would be indistinguishable and reagent volumes were propor-
tionally scaled up to appropriate amounts for 24-well plates.
Statistics
Error bars represent standard error of mean throughout this
article. Statistical comparison of datasets was performed by one
way ANOVA with Fisher[CVOAPS]s LSD (Figs 2C and 6A) or by
two way ANOVA with Tukey[CVOAPS]s post hoc test (all other
figures). Biological replicates are indicated throughout as N in
corresponding figure legends. Biological replicates constitute
cell culture preparations from independent dams.
Results
Characterization of E18 Primary Rat Neuronal Cultures
We dissected brain tissue from the pups of timed-pregnant
Sprague-Dawley rats (Rattus norvegicus) on embryonic day 18
(E18) to obtain dissociated cortical neurons. Cells were then
plated as monolayers in supplemented Neurobasal growth
medium. The identity of these cultured cells was characterized
over the first week of growth by immunocytochemistry (ICC)
using antibodies raised against Nestin, DCX, and NeuN (neural
progenitor, differentiating neuron, and differentiated neuronal
markers, respectively) (Fig. 1) [49–51]. The cultures were com-
posed of cells exhibiting expression of: Nestin and DCX on day 0
in vitro (DIV 0), predominantly DCX expression by DIV 4, and
largely NeuN expression by DIV 7. Based on the expression of
these markers, we identified our DIV 0 cells to be a mixture of
both neuronal progenitors and differentiating neurons, whereas
DIV 4 and DIV 7 cells were predominantly differentiating and
differentiated neurons respectively. Utilizing cultures of this
nature allowed us to investigate the effects of exposure to BDE-
47 and its hydroxylated metabolites across various early stages
of neuronal maturation in vitro.
6OH-BDE-47 Impairs Neuronal Maturation and Activity-
Induced Gene Transcription
Mature neurons sense environmental cues through neuronal
activity and can respond via activity-induced gene transcription
[52]. Therefore, we sought to test the effects of PBDE exposure
on functional maturation by conducting neuronal activity-
induced gene transcription assays using a widely studied,
neuron-specific immediate early gene (IEG), Arc, as a readout
(referred to from here on as ‘activity-induced gene transcription
assay’). Assays were conducted in cultures that were chronically
exposed to 1 lM of BDE-47 or one of its hydroxylated metabo-
lites– 3OH-BDE-47 (3OH), 5OH-BDE-47 (5OH), and 6OH-BDE-47
(6OH) and neuronal activity was induced using Bicuculline and
4AP (Bicþ 4AP). Arc pre-mRNA, the direct output of transcrip-
tion, was detected at 15 min after induction and quantified
by quantitative real-time PCR (qRT-PCR) using intron-exon
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spanning primers. We found that transcription of Arc was sig-
nificantly attenuated in cultures exposed to 6OH from DIV 0-10,
but not in cultures exposed to other compounds (Fig. 2B) sug-
gesting that chronic exposure to 6OH may interfere with func-
tional maturation of neurons.
Lack of functional maturation could be an inadvertent fall-
out of 6OH-induced neurotoxicity or impaired neuronal differ-
entiation. Any cytotoxicity in cells exposed to different doses
of 6OH was measured by MTT assay. This range of doses was
selected based on an approximation of environmentally rele-
vant exposures. The reasoning and justification for this
approximation is detailed further in the discussion. While
1 lM 6OH was found to induce a significant reduction in cell
viability after chronic exposure for ten days, 0.5 and 0.1 lM
6OH doses did not (Fig. 2C). Next, we studied the effect of 6OH
on neuronal differentiation. 6OH has been previously shown
to inhibit differentiation at lower concentrations than its
parent compound in adult neural progenitor cells and human
neuronal precursors [53, 54]. To verify any effect of 6OH on
neuronal differentiation in our system, we stained for neuro-
nal fate markers (NeuN and Tuj1) in DIV 7 neurons after pro-
longed exposure to the non-cytotoxic 0.5 lM 6OH dose
(Fig. 2D–F). On DIV 7, when neurons are differentiated in our
system (Fig. 1), there was no difference in fraction of NeuN
positive neurons between untreated and 6OH treated cultures
(Fig. 2D and E). Similar results were obtained with Tuj1,
another marker for differentiated neurons (Fig. 2F), indicating
that neurons can attain their fate and differentiate irrespec-
tive of exposure to 6OH in our culture conditions. Therefore,
reasons for 6OH exposure-related lack of functional matura-
tion (Fig. 2B) likely lie elsewhere.
Next, to explore any differences in 6OH effects between dif-
ferentiating and differentiated neurons, we conducted addi-
tional activity-induced gene transcription assays, exposing cells
to a range of 6OH concentrations from both DIV 0 and
DIV 7. From these assays, a dose-dependent activity-induced
Arc transcriptional response was observed in cultures exposed
at both DIV 0 and DIV 7 (Fig. 2G and H). Interestingly 0.5 lM 6OH
exposure, which does not significantly affect cell viability, pro-
duced effects that were not statistically different from 1 lM
exposure. Taken together, these results indicate that chronic
6OH exposure impairs functional neuronal maturation while
differentially affecting cell viability depending on the exposure
dose.
6OH-BDE-47 Exposure Impairs Synaptic and Extra-
Synaptic Modules of Activity-Induced Transcription
Transcription of IEGs in response to neuronal activity relies
on a cascade of intracellular components starting with func-
tional synapses, then transduction of signals from the syn-
apse to the nucleus, and finally chromatin accessibility in the
nucleus itself [55, 56]. As Bicþ 4AP treatment induces neuro-
nal activity by GABAergic disinhibition, any of these factors
affected by 6OH could be contributing to the decreased pro-
duction of nascent Arc pre-mRNA in Figure 2. As such, results
from Bicþ 4AP induction assays potentially reflect an accu-
mulation of effects arising from dysregulation at any point
from the synapse to the nucleus. Therefore, to more specifi-
cally test if 6OH was acting at synapses or further down-
stream, we induced Arc transcription intracellularly at the
signal transduction level by stimulating the Mitogen
Activated Protein Kinase (MAPK) pathway, which is known to
transduce signals for rapid neuronal gene transcription [57,
58]. Our laboratory has established that neuronal rapid IEGs,
including Arc [43], may be induced extrasynaptically by acti-
vating the MAPK pathway with 1 lM of the protein kinase C
(PKC) activator phorbol 12-myristate 13-acetate (PMA) while
blocking neuronal activity with 1 lM tetrodotoxin (TTX), a
potent sodium channel blocker (Fig. 3A) [59]. Using this extra-
synaptic induction protocol, we found that Arc is induced
within 15 min. This Arc pre-mRNA induction was inhibited
significantly by 1 lM, but not 0.5 lM or 0.1 lM, 6OH exposure
(Fig. 3C). Although 1 lM 6OH exposure caused a certain
amount of cell death (Fig. 2C), the effect of the same dose seen
in this assay may not be entirely due to neurotoxicity because
the Arc induction values are normalized by an internal control
(Gapdh, representing live cells). Additionally, comparing
Figs 2G and 3C, our data indicate that prolonged exposure to
the non-lethal dose of 6OH (0.5 lM) may impair synaptic for-
mation and/or functions (Bicþ 4AP assays; Fig. 2G), but spares
extra-synaptic cascades of events that lead up to Arc tran-
scription (TTXþ PMA assays; Fig. 3C).
One major suspected mode of action for PBDE toxicity is dys-
regulation of thyroid hormone homeostasis, including disrup-
tion of thyroid hormone levels, transport, and receptor activity
[4]. These effects are thought to be mediated by structural simi-
larity between PBDEs and thyroid signaling molecules [7]. To
Figure 1: Characterization of neuronal cultures across the first week of growth
by immunocytochemistry. Rat cortical neurons were obtained by dissecting and
dissociating cortices from E18 pup brains. Cultures derived from these cells
were stained using antibodies against several markers of neuronal maturation:
Nestin (neuronal precursor), DCX (differentiating neurons), and NeuN (differen-
tiated neurons). Staining was conducted at indicated time points. Scale bar ¼
25lm. N¼3
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test if the observed effects of 6OH in our assays are mediated
primarily by disruption of intracellular thyroid signaling, cul-
tures were co-exposed to 1 lM 6OH and either 30 or 3 nM triiodo-
thyronine (T3), which is present at low levels in culture media
already. Elevated levels of T3 were shown to rescue 10 lM BDE-
47-induced reduction of neuronal migration in another study
[53]. In our assays, elevated levels of T3 did not rescue 1 lM 6OH-
induced attenuation of Arc induction following Bicþ 4AP
Figure 2: Chronic 6OH exposure is detrimental to neuronal maturation and function. Activity induced Arc expression assays were conducted by treating cultures
with Bic and 4AP for 15 min. (A) Timeline depicting PBDE exposure durations leading up to activity induction assays. Ten day exposures were started either con-
currently with plating (DIV 0) or after a week of growth (DIV 7) to assess differences in effect on differentiating versus differentiated neurons. (B) Induction of Arc
after a 10-day exposure to 1lM BDE-47 or one of its hydroxylated metabolites, N¼3. (C) Assessment of cell viability following 10 days of 1lM 6OH-BDE-47 exposure.
Viability was assessed colorimetrically by MTT assay. N¼3. (D) Representative images of NeuN and DAPI stained cells on DIV 7 following treatment with 0.5lM
6OH starting at DIV 0. Scale bar ¼ 50lm (E) Quantification of NeuN and DAPI staining represented in D, (2, 562 untreated and 2, 634 6OH treated cells counted). (F)
Representative western blot for Tuj1 (a marker of differentiated neurons) in cells exposed to 0.5lM 6OH-BDE-47 for seven days, N¼3. (G) Induction of Arc after a
ten-day exposure to various concentrations of 6OH, N¼3. (H) Similar assay as shown in (G) except 6OH exposure was started on DIV 7, N¼4. * P < 0.05, ** P < 0.01.
ns ¼ non-significant
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stimulation, although the addition of 30 nM T3 alone did signifi-
cantly enhance induced Arc transcription (Fig. 3D). Together,
these results indicate that boosted levels of thyroid hormone
cannot rescue effects of 6OH exposure, perhaps including its
neurotoxic effects, opening the possibility of a thyroid-hormone
pathway-independent mechanism of 6OH toxicity.
BDE-47 and Its Hydroxylated Metabolites Dysregulate
Expression of NDD Candidate Genes
Observing that chronic exposure to 6OH disrupts neuronal
activity-related function in dosage-dependent manners, and that
the effects are not primarily mediated by disruption of thyroid hor-
mone homeostasis, we sought to identify other potential mecha-
nisms. To accomplish this, we screened 15 NDD candidate genes,
coding for proteins of various functions important for neuronal
development and function (Table 1), for changes in mRNA levels
following exposure to 1lM BDE-47 or its hydroxylated metabolites.
Exposures were started at various time points to assess effects dur-
ing neuronal differentiation. We found that exposure to BDE-47,
3OH, and 5OH altered mRNA levels of only a few genes, while 6OH
exposure altered mRNA levels of 11 out of 15 genes at the earliest
and middle time points (exposures at DIV 0 and DIV 4), and a
smaller subset when differentiated neurons were exposed starting
at DIV 7 (Fig. 4). This observation suggests that 6OH exposure may
have temporally specific effects, with immature neurons being
affected to a seemingly greater extent. Following up on the wide-
spread effect caused by 6OH, we measured mRNA levels of the
same 15 genes after exposure to a range of 6OH concentrations
over the various time points (Fig. 5). Dysregulation of mRNA levels
by 6OH was found to be dose-dependent, with transcripts of a few
genes exhibiting significant changes at concentrations as low as
10 nM (Arid1b, Tbl1xr1, and Adnp, data not shown). Of particular
interest are Arid1b and Smarcc2, both of which code for subunits of
the BAF chromatin remodeling complex [60], as well as Shank3, a
high confidence autism candidate gene whose protein product is
involved in the organization of the postsynaptic density [61]. In our
screen, Shank3 was significantly dysregulated by 6OH in an oppos-
ing manner depending on the time of exposure (Figs 4 and 5).
Together, these screens demonstrate dysregulation of mRNA lev-
els of several NDD candidate genes by chronic 6OH exposure in a
mammalian model, and further validate the dose- and time-of-
exposure dependence of 6OH toxicity. They also provide many
potential novel targets for further investigation.
While changes in mRNA levels following 6OH exposure can be
informative of altered cellular states, they do not necessarily
indicate direct effects on the transcription of target genes. This is
due to mRNA abundance being a function of the rate of transcrip-
tion as well as of transcript decay, which can vary greatly [62, 63].
To verify if 6OH-induced changes to mRNA levels were due to a
direct effect on the transcription of target genes, we designed pri-
mers to detect pre-mRNAs, the short-lived, direct product of tran-
scription by RNA polymerase II. We focused on genes strongly
affected in differentiating neurons (cultures with exposure start-
ing on DIV0), and measured their respective pre-mRNA levels at
time points within that window of exposure, where early neuro-
nal differentiation is occurring (DIV0-5). Interestingly, as revealed
by MTT assays and unlike what is seen in differentiated neurons
(Fig. 2C), 1lM 6OH did not negatively impact cell viability by DIV3
(Fig. 6A). In these cells, as revealed by pre-mRNA assays, 6OH
exposure impacted most genes only at the mRNA level, perhaps
via indirect mechanisms that influence mRNA half-lives.
However, expression profiles of three of the tested genes were
found to be significantly dysregulated at the pre-mRNA level –
intriguingly, all of which encode BAF complex subunits or inter-
acting proteins (Smarcc2, Arid1b, and Adnp). (Fig. 6B).
A
B
C
D
Figure 3: Effects of 6OH exposure are at the synaptic and extrasynaptic level and
are not primarily mediated by disruption of thyroid hormone signaling. Activity
induced Arc expression assays were conducted by treating cultures with Bic and
4AP or TTX and PMA for 15 min after ten days of 6OH exposure starting at the
time of plating. (A) Depiction of different modes of gene transcription assays.
Note: Bicþ4AP induction (Fig. 2) is reliant on synaptic activity whereas
TTXþPMA induction bypasses synapses and jumpstarts signaling cascades
extra-synaptically. (B) Timeline depicting 6OH exposures with or without addi-
tion of triiodothyronine (T3) followed by various activity induction assays. (C)
Induction of Arc via direct activation of the MAPK pathway with PMA while
blocking membrane activity with TTX in cultures exposed to various concentra-
tions of 6OH N¼5. (D) Induction of Arc with Bicþ4AP following exposure to 6OH
with and without additions of T3 to outcompete potential interactions of 6OH
with thyroid hormone transporters and receptors N¼3. *P < 0.05, **P < 0.01
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6OH-BDE-47 Dysregulates Expression of Smarcc2
(BAF170) and Other BAF Complex Subunits
One of the genes exhibiting 6OH-induced changes in pre-mRNA
level, Smarcc2, codes for BAF170, a core subunit of the mamma-
lian SWI/SNF (SWItch/Sucrose Non-Fermentable)-like BAF com-
plex. BAF complexes are ATP-dependent chromatin remodelers
that play important and fundamental roles in driving neurode-
velopmental processes [64]. BAF170 is thought to act as a scaf-
folding subunit that is critical for the stability of these
complexes [65]. Therefore, to test the effect of 6OH on expres-
sion of other BAF subunits, we screened mRNA levels of other
known subunits of the neuronal precursor and neuron specific
Table 1: Neurodevelopmental disorder candidate genes screened for mRNA dysregulation following chronic exposure to BDE-47 or its hydroxy-
lated metabolites
Gene Description/Function Associated Brain
Disorders
Adnp Activity-Dependent Neuroprotective Protein: zinc finger transcription factor that modulates
p53 activity and interacts with BAF chromatin remodeling complexes to regulate
transcription
ASD [81], ID [82]
Arid1b AT-Rich Interaction Domain 1B (BAF250b): DNA interacting protein, subunit of the neural pre-
cursor and neuron specific BAF chromatin remodeling complexes
ASD [83], ID [82]
Cbx4 Chromobox 4: component of a Polycomb group (PcG) PRC1-like complex which is involved in
transcriptional repression of many genes throughout development and mediates monoubi-
quination of histone 2A lysine 119 residues
ASD [84]
Ctnnb1 Catenin Beta 1: component of the canonical Wnt signaling pathway, coactivator of TCF/LEF
transcription factors that activate Wnt responsive genes which play diverse neurodevelop-
mental roles such as central nervous system patterning, and neural stem and precursor cell
proliferation
ASD [81], ID [82]
Dyrk1a Dual Specificity Tyrosine Phosphorylation-Regulated Kinase 1A: a nuclear protein kinase that
catalyzes autophosphorylation of serine/threonine and tyrosine residues, thought to play a
role in regulating signaling pathways contributing to cell proliferation and
neurodevelopment
ASD [81], ID [82]
Med13l Mediator Complex Subunit 13 Like: a subunit of the mediator complex, a transcriptional coacti-
vator for RNA polymerase II transcribed genes that is recruited to promoters by binding with
regulatory proteins thus serving as a scaffold for the preinitiation complex, involved in early
neurodevelopment
ASD [84], ID [82]
Ncor1 Nuclear Receptor Corepressor 1: corepressor of thyroid-hormone and retinoic-acid receptor tar-
get genes, known to recruit histone deacetylases that promote the formation of condensed
chromatin structure that prevents access of transcription factors and thus represses
transcription
ASD [84], HD [85]
Npas2 Neuronal PAS Domain Protein 2: transcription factor that is a core component of the circadian
clock, also known to regulate the transcription of metabolism, cell cycle, and DNA repair
related genes
ASD [86]
Phf2 PHD Finger Protein 2: a zinc-finger-like plant homeodomain containing demethylase that acts
on both histone and non-histone proteins, dimerizes with Arid5b at target promoters and
demethylates histone 3 lysine 9 (H3K9me2) residues leading to transcriptional activation
ASD [84]
Rps6ka2 Ribosomal Protein S6 Kinase A2: a member of the RSK family of serine/threonine kinases that
phosphorylates members of the mitogen-activated protein kinase signalling pathway, regu-
lates processes such as cell growth, survival, and proliferation
ASD [87]
Shank3 SH3 and Multiple Ankyrin Repeat Domains 3: major scaffold protein of the postsynaptic density
that organizes neurotransmitter receptors, ion channels, and other membrane proteins via
interactions with the actin cytoskeleton, plays a role in dendritic spine maturation as well as
synaptic formation and plasticity
ASD [88], ID [89], SCZ [90]
Smarcc2 SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin Subfamily C
Member 2 (BAF170): subunit of the neural precursor and neuron specific BAF chromatin
remodeling complexes, thought to be a scaffolding subunit required for stabilization of other
BAF subunits, involved in transcriptional activation and repression, known to regulate corti-
cal thickness and neural progenitor proliferation
ASD [91], ID [92], SCZ [41]
Sp1 Specificity Protein 1: a zinc finger transcription factor that binds GC-rich motifs at many pro-
moters, involved in many cellular processes such as differentiation, growth, apoptosis, and
recruitment of chromatin remodeling enzymes including Brg1 and Brg associated factors to
regulate transcription
ASD [93]
Tbl1xr1 Transducin Beta Like 1 X-Linked Receptor 1: thought to be a component of the NCoR and
HDAC3 repressive complexes, and is required for transcriptional activation by a variety of
transcription factors
ASD [81], ID [94]
Ubr3 Ubiquitin-Protein Ligase E3-Alpha-3: targets proteins for degradation by ubiquinitination, may
be involved in chromatin regulation and transcriptional silencing (by similarity)
ASD [81]
Abbreviations: ASD- autism spectrum disorder, ID- intellectual disability, SCZ- schizophrenia, HD- Huntington[CVOAPS]s disease
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BAF complexes (npBAF/nBAF) and found significant upregula-
tion of several additional subunits, namely, Brm, Brg1, BAF60a,
BAF53a, and BAF47 (Fig. 7A). Focusing on BAF170, we then
sought to confirm 6OH-induced dysregulation of this major BAF
subunit at the protein level by Western blotting. Here, to our
bewilderment, we encountered two opposing outcomes with
almost equal frequency across replicates. In some trials, chronic
exposure of differentiating neurons to 0.1-1 lM 6OH downregu-
lated BAF170 protein levels. In others, BAF170 protein levels
were upregulated by the same treatment (Fig. 7B). Initially
baffling, such vacillating outcomes may be explained if expres-
sion of BAF170 oscillates during neuronal differentiation and
6OH exposure shifts the oscillation frame (Fig. 7B). This hypoth-
esis is supported by previous work that found the expression of
BAF170 to be very dynamic across mouse corticogenesis [66]
and biphasic in H1 embryonic stem cells [44]. To test this possi-
bility, we collected samples at 6 h intervals after plating for the
first 48 h and then assessed BAF170 protein levels by western
blotting. As shown in Fig. 7C (quantified in Fig. 7D), BAF170 lev-
els were found to oscillate with time. Next, we attempted to
Figure 4: Exposure to BDE-47 and its hydroxylated metabolites dysregulates mRNA levels of neurodevelopmental disorder candidate genes. 15 neurodevelopmental
disorder-associated genes screened for changes in mRNA abundance by qRT-PCR following exposures to 1lM BDE-47 or one of its hydroxylated metabolites for periods
indicated below each heatmap. Each row depicts changes in mRNA level for a gene while each column reflects exposure to a different compound. Results are displayed
as fold change relative to control. Cells with a fold change above two have saturated coloring. * P < 0.05, ** P < 0.01. N¼3–5
Figure 5: Dysregulation of neurodevelopmental disorder candidate gene mRNA levels by 6OH is dose- and time-of-exposure-dependent. 15 neurodevelopmental disor-
der-associated genes screened for changes in mRNA abundance by qRT-PCR following exposures to various concentrations of 6OH for periods indicated below each
heatmap. Each row depicts changes in mRNA level for a gene while each column reflects exposure to a different concentration of 6OH. Results are displayed as fold
change relative to control. Cells with a fold change above two have saturated coloring. * P < 0.05, ** P < 0.01. N¼3–4
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quantify such oscillation with and without 6OH exposure. To
our surprise, these oscillations varied greatly between biological
Ns, occluding any statistical analysis after averaging data from
multiple trials. Despite such variations, 6OH treatment consis-
tently altered the oscillatory pattern in every N (5 attempted;
three displayed in Fig. 7E), providing support to our ‘altered
BAF170 oscillation’ hypothesis (Fig. 7B).
These BAF170 protein data, alongside its altered pre-mRNA
and mRNA levels, and the observed alterations to mRNA levels
of other BAF subunits, indicate that 6OH exposure likely influ-
ences BAF complex composition/stability and, therefore, poten-
tially impacts BAF-dependent functions during neuronal
differentiation, including chromatin remodeling and regulation
of gene transcription.
Role of BAF170 in Neuronal Maturation and Activity
Induced Arc Transcription
Finally, to directly study effects of BAF170 dysregulation on
functional maturation of neurons, as would be expected due to
6OH-induced oscillation, we bi-directionally altered its levels in
developing cells (DIV 0-4) by either overexpressing BAF170, or
depleting it via RNAi (lentivirus-mediated delivery of BAF170
shRNA). Both methods were validated by western blot (Fig. 8D
and G). We then performed synapse-dependent and synapse-
independent Arc induction assays. The phenotypic outcomes of
these assays were unaffected by overexpression of BAF170
(Fig. 8B and C). Interestingly, depletion of BAF170 impaired Arc
induction in the synapse-dependent Bicþ 4AP assay (Fig. 8E),
but not in the synapse-independent PMAþTTX assay (Fig. 8F).
This observation is reminiscent of the effects of lower 6OH
doses on Arc induction using these protocol (Figs 2 and 3D).
Additionally, we found that depletion of BAF170 reduces protein
levels of other BAF subunits (Fig. 8G). These observations sup-
port the idea that BAF170 acts as a scaffolding component in
BAF complexes and indicates that dysregulation of BAF170 may
effectively alter BAF complex stability and composition (Fig. 7A)
[65]. Interestingly, BAF155 protein levels did not decrease while
other subunits, namely BAF60a and BAF47 whose mRNA levels
were significantly upregulated following 6OH exposure (Fig. 7A),
exhibited reduced protein levels following loss of BAF170 by
RNAi (Fig. 8G).
Taken together, our data suggest that BAF170 depletion, not
its overexpression, likely impairs neuronal maturation via
synapse-dependent mechanisms, but not extra-synaptic com-
ponents of activity-induced gene transcription. As effects of
BAF170-KD are highly evocative of the effects of 6OH exposure,
we propose that environmentally-relevant doses of 6OH may
act via dysregulation of the BAF complex, especially BAF170, to
interfere with neuronal maturation and function.
Discussion
In this study, we have demonstrated several novel aspects of
PBDE neurotoxicity. Initially, we show the effects of chronic
nanomolar range exposures to BDE-47 and its hydroxylated
metabolites on neuronal activity-induced gene transcription
and functional maturation of primary embryonic rat cortical
neurons. We then demonstrate how similar exposures impact
transcription of NDD candidate genes by quantification of
mRNA and pre-mRNA levels. One of the strongest candidates
from our screen, Smarcc2, then prompted us to focus on the
effects of 6OH exposure on BAF170 expression and, preliminar-
ily, on BAF170-related regulation of neuronal maturation by
measuring levels of activity-induced Arc expression. Together,
our results indicate that exposure to the hydroxylated BDE-47
metabolite 6OH strongly influences functional maturation of
neurons, potentially independent of thyroid hormone disrup-
tion mechanisms– perhaps instead exerting effects mediated in
part at the level of epigenetic regulation via disruption of BAF
chromatin remodeling complexes.
Our utilization of the activity-induced transcription of an
immediate early gene (Arc) as a readout of functional neuronal
maturation is, to the best of our knowledge, a novel approach
in assessing the neurotoxicity of PBDEs. Immediate early gene
induction is a strong tool to this end as it relies on several
A B
Figure 6: Exposure to 6OH dysregulates pre-mRNA levels of a subset of genes affected at the mRNA level. (A) Assessment of cell viability following 3 days of exposure
to 1lM 6OH. Viability was assessed colorimetrically by an MTT assay. N¼3. (B) A subset of neurodevelopmental disorder associated genes found to have dysregulated
mRNA levels following 6OH exposure were screened for changes in pre-mRNA abundance which better reflect effects on transcription of a given gene. Time points
within the earliest exposure period (DIV 0-7) were chosen to more clearly observe direct effects of 6OH toxicity. *P < 0.05, **P < 0.01. N¼3–7
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critical cellular mechanisms that are established across neuro-
nal maturation, ranging from proper synaptic function to
nuclear regulation of gene transcription (Fig. 3A), allowing us
to broadly assess the extent of PBDE-induced effects on func-
tional neuronal maturation. Further, inducing Arc expression
both synaptically (Bicþ 4AP) and extra-synaptically
(TTXþPMA) allowed us to hone in on where these neurotoxic
effects are being exerted. These assays reveal that 6OH-BDE-47
interferes with neuronal maturation likely at the synaptic
level.
As mentioned previously, the range of PBDE doses used in
this study were estimated based on prior work done in mamma-
lian models to approximate relevant concentrations observed in
the brains of exposed animals. To determine this range, an
exhaustive review was conducted of literature reporting levels
of BDE-47 accumulation in rodent brain following either chronic
A
B
C
E
D
Figure 7: BAF170 protein levels and mRNA levels of BAF complex subunits are dysregulated by 6OH exposure. (A) Abundance of various BAF protein mRNAs estimated
by qRT-PCR following exposure to various concentrations of 6OH from DIV 0-7, N¼3–4. (B) Top: BAF170 protein levels observed by western blotting following 48 h of
exposure to various concentrations of 6OH. N¼6. Bottom: opposing outcomes can be explained if BAF170 is expressed in an oscillatory manner and 6OH exposures dis-
rupt regulatory mechanisms shaping the temporal expression patterns. (C) Time-course western blot for BAF170 with samples collected every 6 h after plating for the
first 48 h. (D) Quantification of BAF170 band intensities from blot shown in (C) as an example and evidence of BAF170 oscillation in normal cells. (E) Quantification of
similar time-course experiments as in (C), with collections every 6 h starting 24 h after plating. Note the inherent variation in oscillatory pattern. Cells were either
untreated or exposed to 1 lM 6OH at the time of plating. N¼4 (3 represented) *P < 0.05, **P < 0.01. Note: Because of inherent variation in the oscillatory pattern, averag-
ing these data sets ‘flatten’ out the phenotype and is therefore not attempted
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or single dose administration [67–73]. After converting the com-
monly reported unit of ng/g of toxin to nmol/L (converting from
lipid concentration to molarity), the average concentration of
BDE-47 was determined to be 597 nM. Studies investigating the
in vitro effects of PBDEs have often been conducted using con-
centrations in the low to mid micromolar range. Summarizing
human studies, the USEPA’s 2010 report assessing the environ-
mental prevalence of PBDEs estimated the body burden of total
PBDEs in the general population to be 30-100 ng/g (approxi-
mately 60 to 200 nM), with toddlers tending to have higher body
burdens compared to older children and adults. Importantly,
BDE-47 alone was estimated to account for 50% of total PBDE
concentrations [16]. It has also been reported that hydroxylated
metabolites of PBDEs accumulate in human serum and are
nearly as abundant (approximately 45% of total detectable
PBDEs) as parent PBDE compounds in human fetal blood sam-
ples collected in the United States [13, 14]. Considering the
reported brain accumulation levels of BDE-47 in rodents, con-
centrations commonly used for in vitro studies to date, and the
prevalence of BDE-47 and its hydroxylated metabolites in
humans, we used a range of 100-1, 000 nM BDE-47 and its
hydroxylated metabolites for our studies. This range spans
reported accumulated concentrations in rodent brain, is low rel-
ative to previous in vitro studies, and is on the same order of
magnitude as reported human levels of PBDEs and their
metabolites.
It has been previously demonstrated that micromolar BDE-
47 exposures decrease both neuronal and oligodendrocyte dif-
ferentiation in human neural progenitor cells [53]. Another
study found that BDE-47 and 6OH decrease neuronal and oligo-
dendrocyte differentiation of mouse adult neural stem cells
(aNSC), with 6OH producing an effect following nanomolar
exposures, at concentrations approximately 20 times lower
than its parent compound [54]. Using activity-induced gene
transcription assays as a readout in cultured embryonic rat cort-
ical neurons, we found that chronic nanomolar exposure to
6OH disrupts functional maturation. These effects were found
to be independent of 6OH cytotoxicity or alteration of differen-
tiation for 0.5 lM exposures. Many of the observed effects were
found to be dose-dependent whereas transcriptional profiles
(Figs 4 and 5) were additionally sensitive to time of exposure.
Additionally, these functional effects appear to be mediated
at both synaptic and extra-synaptic levels, as evidenced by
decreases in Arc induction following Bicþ 4AP and TTXþPMA
A
B C D
E F G
Figure 8: BAF170 contributes to the stability of BAF subunits and proper circuit formation, but is not required for MAPK stimulated Arc transcription. (A) Depiction of
the timing of lentiviral mediated manipulation of BAF170 levels and subsequent activity induced Arc induction assays. (B, C) Arc induction following Bicþ4AP or
TTXþPMA stimulation in cells overexpressing BAF170, N¼3. (D) Representative western blot validating BAF170 overexpression construct. (E,F) Arc induction following
Bicþ4AP or TTXþPMA stimulation in cells depleted of BAF170, N¼3. (G) Representative western blots demonstrating the effect of BAF170 knockdown on protein levels
of other BAF complex subunits, N¼3. **P < 0.01. ns ¼ non-significant
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treatments. Effects on IEG transcription by both assays indicate
that 6OH, at higher doses, may act to compromise cell viability,
disrupt mature synapse formation, as well as interfere with cel-
lular mechanisms at or downstream of the MAPK pathway that
regulate activity-induced Arc transcription (Figs 2 and 3).
Interestingly, addition of excess levels of the thyroid hormone
triiodothyronine (T3) did not produce any phenotypic rescue (as
seen previously for BDE-47 induced impairment of neuronal
migration) [53] of the observed attenuation of Arc induction.
This advocates for additional modes of PBDE toxicity, perhaps
acting alongside disruption of thyroid hormone signaling.
However, we also note that 1 lM 6OH-induced cytotoxicity parti-
ally confounds interpretation of this attempted T3 rescue, as
reduction of overall cell viability may obscure potential reversal
of the effects of 6OH exposure by T3. To explore alternate modes
of PBDE toxicity within a context of the relation of PBDE expo-
sure to NDDs, we screened 15 NDD candidate genes, many of
which are epigenetic regulators (Table 1), for changes in mRNA
level. Subsequently, we found that, while exposure to the
parent compound and its other hydroxylated metabolites sig-
nificantly impacted only a few of these targets, 6OH dysregu-
lated mRNA levels of many of the screened genes. These
included Shank3, which encodes an important synaptic protein,
supporting our inference related to detrimental synaptic effects
of persistent 6OH exposure.
Of the genes dysregulated by 6OH exposure, a smaller
subset additionally exhibited altered levels of pre-mRNA, indi-
cating a direct effect of 6OH on transcription of these genes.
Surprisingly, each of the genes whose pre-mRNA was found
to be significantly dysregulated encode BAF chromatin remodel-
ing complex subunits or interacting proteins (Adnp, Arid1b,
Smarcc2). One of these genes, Smarcc2, encodes a critical core
subunit known to contribute to overall BAF complex stability
and composition, BAF170. Protein levels of BAF170 were subse-
quently found to be dysregulated by 6OH exposure, though in a
complex oscillatory manner that remains to be fully character-
ized. It may be the case that as lack of BAF170, but not over-
abundance, is detrimental for neurons (as we have shown in
Fig. 8), the cells are responding to repeated periods of lack of
sufficient BAF170 by upregulating Smarcc2, while protein levels
vary due to post-translational regulation.
BAF170 is a striking candidate whose dysregulation may
contribute to the observed effects of 6OH toxicity, owing to its
critical contribution to BAF complex function. It has been shown
to regulate the stability of BAF chromatin remodeling com-
plexes by acting as a scaffolding subunit and preventing degra-
dation of other BAF proteins. Our results support this notion
and demonstrate a reduction of protein levels of several BAF
subunits upon BAF170-KD (Fig. 8G), an effect previously only
seen with removal of both BAF170 and another interchangeable
complex subunit, BAF155 [65]. This may indicate that BAF170
plays a larger role in stabilizing BAF complexes or specific subu-
nits during the periods of neuronal maturation investigated in
this study. This stabilizing aspect of BAF170 function, making it
critical for BAF complex function as a whole, is intriguing as
BAF complexes have well known roles in neuronal differentia-
tion and maturation [60], and are thought to contribute to regu-
lating activity-induced gene transcription [74–76]. As such,
periods of 6OH induced lack of BAF170 during early stages
where differentiation and maturation are taking place in our
cultures may compromise the functional maturation of cells,
leading to the observed decrease in Arc expression when
assayed at later time-points.
Accordingly, we have shown that reduction of BAF170 levels
by RNAi, but not its overexpression, negatively impacts neuro-
nal maturation using Arc induction as a readout, recapitulating
the effect of exposure to 0.5 lM 6OH following Bicþ 4AP treat-
ment. The lack of effect seen after BAF170 depletion on extra-
synaptically induced Arc (TTX-PMA protocol), as was the case
with lower doses of 6OH in Figure 3C, indicates that BAF170-
containing BAF complexes may not be necessary for nuclear
regulation of activity-induced Arc transcription, but most likely
contribute to synapse maturation and function via transcription
regulation of other genes. These findings are consistent with
recent evidence supporting the idea that BAF complexes are
crucial for synapse formation and maturation during early neu-
ronal development [75]. The same study implicated a role of
Brg1, a core BAF complex ATPase, in activity-induced gene tran-
scription 6 h after onset of activity. However, as our data indi-
cate, BAF170-containing BAF complexes are not specifically
required for Arc induction at early time points if activity is
induced extra-synaptically, likely owing to it[CVOAPS]s poised
transcriptional status [43]. This lack of effect following BAF170
depletion and TTXþ PMA treatment may be gene-specific as
various IEGs are regulated in differing manners [43, 52, 76].
While our current work potentially opens new avenues to
explore the effects imposed by hydroxylated BDE-47 metabo-
lites on epigenetic regulation during neuronal maturation and
activity-induced gene expression, there are limitations to our
study. Although we have demonstrated that exposure to 6OH
has a strong effect on BAF170 expression, from the pre-mRNA
to protein level, the effect is of a complex nature, whose mecha-
nistic basis we do not yet fully understand. Consistant with our
findings, the multiphasic expression pattern of BAF170 has
been previously demonstrated during corticogenesis in mice
[66] and in H1 embryonic stem cells [44], but further investiga-
tion will be required to fully characterize the expression profile
of BAF170 and regulatory mechanisms that shape it.
Additionally, like much PBDE research, we have investigated
the effects of exposure to a single toxin at a time, while the
developing human nervous system is realistically exposed to
complex mixtures of pollutants. Some studies have been com-
pleted demonstrating effects of coexposures to environmental
pollutants both in vitro and in vivo using combinations of PBDE
congeners, other toxins including polychlorinated biphenyls
(PCBs), and commercially available mixtures such as DE-71 [77–
80]. More such studies will be needed to address the effects
resulting from environmentally relevant mixtures of com-
pounds, especially with concern to their metabolites.
Finally, our results show that nanomolar range exposures to
the BDE-47 hydroxylated metabolite 6OH strongly impact sev-
eral aspects of neuronal maturation and function and that these
effects are likely, at least in part, mediated by disruption of BAF
chromatin remodeling complexes via dysregulation of BAF170
expression. Going forward, it will be important to fully charac-
terize the regulatory mechanisms governing the intricate
expression of BAF170 to discern precisely how the observed
PBDE-induced dysregulation is produced. Additional investiga-
tion of the underlying mechanisms that mediate the neurotoxic
effects of PBDE at the level of epigenetic regulation may lead to
a better understanding of how exposure to these compounds
leads to developmental complications and NDDs as well as
to further characterization of fundamental neuroepigenetic
processes.
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